Nyloxin

Nutra Pharma is Excited to Announce: Luxury Feet now Available on Amazon

Apr 15, 2021

Nutra Pharma is announcing their newest product, Luxury Feet; is now available for purchase on Amazon.com Plantation, Florida, April 15, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that their newest product, Luxury...

Nutra Pharma Announces Distribution of Luxury Feet for the Relief of Pain from High Heels

Mar 16, 2021

Nutra Pharma is announcing the marketing and distribution plans for Luxury Feet; an over-the-counter pain reliever for women who experience pain or discomfort due to high heels and stilettos Plantation, Florida, March 16, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human...

Nutra Pharma Engages Quality and Regulatory Professionals Ahead of Clinical Trials

Mar 11, 2021

Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation in preparation of expanded OTC sales and clinical trials Plantation, Florida, March 11, 2021 -- -- Nutra Pharma Corporation (OTC Pink: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple...

Nutra Pharma Provides Updates on Laboratory Upgrades and Certifications

Feb 23, 2021

Nutra Pharma is providing updates on their work in improving capabilities and certifications in their laboratory for drug production and validation Plantation, Florida, February 23, 2021 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain,...

Nutra Pharma Announces New Intellectual Property Update and Engages Additional Intellectual Property Attorneys

Feb 12, 2021

Plantation, Florida, February 12, 2021 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that they are focusing on their intellectual property portfolio and have engaged their IP attorneys at Christopher & Weisberg P.A....

Nutra Pharma Letter to Shareholders

Jan 12, 2021

Plantation, Florida, January 12, 2021 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, announced today that the Company's Chief Executive Officer, Rik J Deitsch, has published a Letter to Shareholders on the Company's website. “The last year was...

Nutra Pharma Announces Nyloxin Now Available on the Walmart Marketplace

Nov 11, 2020

Nutra Pharma announces that its all-natural pain reliever, Nyloxin, has been accepted by the Walmart Marketplace and is now available there for purchase Plantation, Florida, November 11, 2020 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, has...

Nutra Pharma Provides Financing Updates and the Elimination of Institutional Debt

Nov 4, 2020

Nutra Pharma is providing updates regarding debt restructuring and financing plans Plantation, Florida, November 4, 2020 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their plans and progress involving financing,...

Nutra Pharma Provides Business and Compliance Updates

Nov 3, 2020

Nutra Pharma is providing updates regarding their business plans, accounting and compliance Plantation, Florida, November 3, 2020 -- -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin®, Pet Pain-Away and Equine Pain-Away in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV) and Pain, provided updates today on their plans and progress on improving...

Nutra Pharma Provides Updates on Marketing and Distribution

Aug 7, 2020

Coral Springs, Florida, March 3, 2020 -- Nutra Pharma Corporation (OTC PINK: NPHC), a biotechnology company marketing Nyloxin® and Pet Pain-Away™ in the over-the-counter (OTC) pain management market and which is also developing treatments for Multiple Sclerosis (MS), Human Immunodeficiency Virus (HIV), Adrenomyeloneuropathy (AMN) and Pain, provided updates today on their progress in the marketing and distribution of Nyloxin, Pet Pain-Away and Equine Pain-Away. “We have been very busy in laying...

NEWSROOM